ACM
IGMS

Aquatic Capital Management’s IGM Biosciences IGMS Stock Holding History

Aquatic Capital Management’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,500
Closed -$42K – 1490
2022
Q4 		$42K Buy
+2,500
New +$50K ﹤0.01% 1040
2022
Q3 		– Sell
-600
Closed -$11K – 1349
2022
Q2 		$11K Sell
600
-100
-14% -$1.78K ﹤0.01% 955
2022
Q1 		$19K Buy
+700
New +$13K 0.03% 505

Other funds holding IGMS

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Aquatic Capital Management's IGMS Position: Q1 2023 in Review

Aquatic Capital Management sold out of IGM Biosciences (IGMS) in Q1 2023, closing a stake of 2,500 shares — an estimated $42K sold.

Aquatic Capital Management first reported a position in IGMS in Q1 2022 and held it in 3 quarters. The position peaked at $42K in Q4 2022. 74 funds tracked by Wall St. Rank hold IGMS as of Q1 2023.

  • Aquatic Capital Management reported no remaining IGM Biosciences position as of Q1 2023 after selling out during the quarter.
  • Aquatic Capital Management sold 2,500 IGM Biosciences shares in Q1 2023, an estimated $42K.
  • Aquatic Capital Management first reported a position in IGM Biosciences in Q1 2022 and held it in 3 quarters.
  • Aquatic Capital Management's IGM Biosciences position peaked at $42K in Q4 2022.
  • 74 funds tracked by Wall St. Rank held IGM Biosciences as of Q1 2023.

Based on Aquatic Capital Management's 13F filing for Q1 2023, filed 15 May 2023.